Skip to main content
. 2023 Jul 13;20(14):6358. doi: 10.3390/ijerph20146358

Table 1.

Overview of the final attributes for the DCE in each clinical field (with attribute descriptions and level descriptions).

COCHLEAR-DCE
Attribute Attribute Description Level 1 (Reference) Level 2 Level 3
Decision making Final decision on the implantation of a specific manufacturer’s CI model lies… Only with your doctor [decisionDOC] With you and your doctor [decisionSHARED, β1] Only with you [decisionPAT, β2]
Information source Obtaining information about developments regarding the CI and care context: Through own research [infoRESEARCH] Automatically by the manufacturer [infoMANU, β3] Automatically by the clinic or audiologist [infoCLINIC, β4]
Access to alternative treatments in the future Other treatment options after CI implantation, which are still being researched and may be available in the future... Are excluded [futureoptionEXCLUDED] Remain available [futureoptionPRESERVE, β5] -
Technological compatibility Compatibility with newer CI models and accessories or devices from other manufacturers Not compatible [technUNCOMPATIBLE] Compatible [technCOMPATIBLE, β6] -
Care relationship in aftercare Carrying out aftercare: Fixed staff of professionals who are in exchange [aftercareFIXED] Varying professionals according to specific needs [aftercareVARYING, β7] -
Education Education regarding adjustments, decisions and innovations regarding your CI is... Not very comprehensive [educationLITTLE] Very comprehensive [educationCOMPR, β8] -
GLAUCOMA-DCE
Attribute Attribute description Level 1 (Reference) Level 2 Level 3
Decision making Final decision on the implantation of a specific manufacturer’s CI model lies… Only with your doctor [decisionDOC] With you and your doctor [decisionSHARED, β1] Only with you [decisionPAT, β2]
Means in case of implant failure Corrective measure in the event that the implant does not (or no longer) work Implant stays in the eye [failureSTAY] Correction by means of intervention [failureCORRECTION, β3] Implant removal [failureREMOVAL, β4]
Probability of treatment success Chances of success of still not needing glaucoma medication 2 years after implantation are: Over 50% [chancesofsuccessLOWER] Over 75% [chancesofsuccessHIGHER, β5] -
Information source Information that goes beyond implantation and aftercare (e.g., on nutrition, drops for dry eyes, glasses, etc.) will be provided… In the context of implant care from the medical side [infosourceMEDICAL] From independent information sources (e.g., glaucoma forum) [infosourceINDEPENDENT, β6] -
Data transparency Statistics and empirical values on implantation in the treating clinic… Are not available [dataNONAVAILABLE] Are available [dataAVAILABLE, β7] -
Information exchange between health professionals Exchange of information between different health professionals (e.g., resident ophthalmologist, family doctor and clinic) You coordinate yourself [infoexchangePAT] Takes place automatically [infoexchangeAUTOM, β8] -
CARDIOVASCULAR-DCE
Attribute Attribute description Level 1 (Reference) Level 2 Level 3
Decision making Final decision on the implantation of a specific manufacturer’s CI model lies… Only with your doctor [decisionDOC] With you and your doctor [decisionSHARED, β1] Only with you [decisionPAT, β2]
Information source Information that goes beyond implantation and aftercare (e.g., on nutrition, lifestyle, etc.) will be provided… In the context of implant care from the medical side [infoMEDICAL] From independent information sources (e.g., German Heart Foundation) [infosourceINDEPENDENT, β3] -
Data transparency Statistics and empirical values on stent implantation in the treating heart clinic… Are not available [dataNONAVAILABLE] Are available [dataAVAILABLE, β4] -
Information exchange between health professionals Exchange of information between different health professionals (e.g., family doctor, clinic and other health professionals) You coordinate yourself [infoexchangePAT] Takes place automatically [infoexchangeAUTOM, β5] -
Means of maintaining treatment success The long-term success of the treatment can be secured by… Lifelong medication (e.g., blood thinners) [successMEDICATION] New implant every 10 years [successREIMPL, β6] -
Invasiveness of intervention The implant is inserted… Minimally invasive (without opening the chest) [invasivenessMIN] Surgical (chest opening) [invasivenessSURGERY, β7] -

Note. []—Given in square brackets are the names of the variables used in the regression analysis relating to each attribute level and the corresponding beta coefficients.